15 Participants Needed

High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type 2 Diabetes: the Role of Interval Length on Clinical Benefits and on Physiological Mechanisms

ER
Overseen ByEléonor Riesco, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Université de Sherbrooke
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two types of high-intensity interval training (HIIT) on elderly women with type 2 diabetes. It aims to see if longer exercise intervals are better than shorter ones at lowering blood pressure and improving blood sugar control. The study also looks at how these exercises affect inflammation in the body. High-intensity interval training (HIIT) has been shown to improve glycemic control and cardiometabolic risk in people with type 2 diabetes.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on insulin therapy or beta blockers, or if your medication has been unstable in the past 6 months.

Is high-intensity interval training (HIIT) generally safe for humans?

High-intensity interval training (HIIT) is generally considered safe for humans, including older adults and those with cardiovascular diseases, when done under appropriate supervision. Studies show a low rate of major adverse events, but caution is advised for people with specific health conditions, and they should consult with healthcare professionals before starting HIIT.12345

How does HIIT-10 and HIIT-4 differ from other treatments?

High-intensity interval training (HIIT) is unique because it involves short bursts of intense exercise followed by rest, which can improve fitness and fat burning more effectively than traditional moderate-intensity exercise. This approach can be particularly beneficial for improving heart health and fitness levels in a shorter amount of time compared to continuous exercise routines.678910

What data supports the effectiveness of the treatment High-intensity interval training (HIIT)-10, High-intensity interval training (HIIT)-4, Rest, Restoril, Temazepam?

Research shows that high-intensity interval training (HIIT) can improve cardiorespiratory fitness in cancer patients and survivors, which may help them recover better and improve their overall health. Additionally, HIIT has been found to reduce fatigue and improve physical function in patients undergoing chemotherapy.1112131415

Are You a Good Fit for This Trial?

Inclusion Criteria

Low or no alcohol consumption (≤ 7 alcoholic beverages/week)
You have been regularly exercising for at least 60 minutes per week for the past 3 months.
Arterial hypertension (controlled at rest)
See 2 more

Exclusion Criteria

Surgery scheduled during the study period
Unstable medication in the past 6 months
Neuropathy, retinopathy of nephropathy diagnostics
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Rest

Participants undergo a rest condition as a baseline measure before HIIT interventions

1 week
1 visit (in-person)

HIIT-4

Participants perform high-intensity interval training with 4x4 minute intervals

1 week
3 visits (in-person)

HIIT-10

Participants perform high-intensity interval training with 10x1 minute intervals

1 week
3 visits (in-person)

Follow-up

Participants are monitored for changes in clinical parameters such as blood pressure and glycemic control

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • High-intensity interval training (HIIT)-10
  • High-intensity interval training (HIIT)-4
  • Rest
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Rest, HIIT-4, HIIT-10Experimental Treatment3 Interventions
Group II: Rest, HIIT-10, HIIT-4Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Université de Sherbrooke

Lead Sponsor

Trials
317
Recruited
79,300+

Published Research Related to This Trial

High-intensity interval training (HIIT) has been shown to significantly improve cardiorespiratory fitness in breast cancer survivors, based on a review of 13 randomized controlled trials.
All HIIT interventions were supervised and lab-based, indicating a need for further research into the feasibility and effectiveness of home-based or unsupervised HIIT programs for this population.
High-intensity interval training in breast cancer survivors: a systematic review.Tsuji, K., Matsuoka, YJ., Ochi, E.[2021]
A randomized trial involving 151 patients with operable lung cancer found that preoperative high-intensity interval training (HIIT) rehabilitation did not lead to significant improvements in pulmonary function or aerobic capacity one year after surgery.
Both the rehabilitation group and the usual care group showed similar reductions in peak oxygen uptake and peak work rate, indicating that the short-term HIIT intervention did not enhance long-term postoperative outcomes.
Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled study.Karenovics, W., Licker, M., Ellenberger, C., et al.[2022]
High-intensity interval training (HIIT) significantly improves cardiorespiratory fitness (measured as peak V̇O2) in cancer patients and survivors compared to usual care, with a mean difference of 2.11 ml kg-1 min-1.
HIIT shows similar effectiveness to moderate-intensity continuous training (MICT) in improving peak V̇O2, while also demonstrating better adherence rates (71.2% to 95.6%) and no serious adverse events reported.
High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis.Wallen, MP., Hennessy, D., Brown, S., et al.[2021]

Citations

High-intensity interval training in breast cancer survivors: a systematic review. [2021]
Functional and postoperative outcomes after high-intensity interval training in lung cancer patients: A systematic review and meta-analysis. [2023]
Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled study. [2022]
High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis. [2021]
Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial. [2019]
High-Intensity Interval Training in Older Adults: a Scoping Review. [2021]
High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review. [2021]
What Doesn't Kill You Makes You Fitter: A Systematic Review of High-Intensity Interval Exercise for Patients with Cardiovascular and Metabolic Diseases. [2022]
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
High-Intensity Interval Training in Patients with Pulmonary Embolism: A Randomized Controlled Trial. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Greater improvement in cardiorespiratory fitness using higher-intensity interval training in the standard cardiac rehabilitation setting. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Effect of two doses of interval training on maximal fat oxidation in sedentary women. [2018]
High-intensity interval versus moderate-intensity continuous half-marathon training programme for middle-aged women. [2021]
Acute responses and muscle damage in different high-intensity interval running protocols. [2022]
15.United Statespubmed.ncbi.nlm.nih.gov
Cardiac autonomic function and high-intensity interval training in middle-age men. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security